Eugène Cox

1.3k total citations
22 papers, 623 citations indexed

About

Eugène Cox is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Eugène Cox has authored 22 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Eugène Cox's work include Neuroscience and Neuropharmacology Research (6 papers), Pain Mechanisms and Treatments (5 papers) and Epilepsy research and treatment (4 papers). Eugène Cox is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Pain Mechanisms and Treatments (5 papers) and Epilepsy research and treatment (4 papers). Eugène Cox collaborates with scholars based in United States, United Kingdom and Netherlands. Eugène Cox's co-authors include Meindert Danhof, Paul M. Diderichsen, M.W.E. Langemeijer, Florence Namour, Annegret Van der Aa, Chantal Tasset, Béatrice Vayssière, John Maringwa, Piet H. van der Graaf and Thomas Kerbusch and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesiology and British Journal of Pharmacology.

In The Last Decade

Eugène Cox

22 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugène Cox United States 12 182 154 117 93 85 22 623
Rosalin Arends United States 14 358 2.0× 214 1.4× 201 1.7× 40 0.4× 63 0.7× 22 1.0k
Marc Hattenberger Switzerland 7 139 0.8× 195 1.3× 82 0.7× 40 0.4× 26 0.3× 7 550
Christodoulos Flordellis Greece 17 74 0.4× 368 2.4× 80 0.7× 40 0.4× 56 0.7× 45 883
Dennis Swearingen United States 13 81 0.4× 119 0.8× 53 0.5× 70 0.8× 26 0.3× 28 444
Baoguang Han United States 16 87 0.5× 707 4.6× 55 0.5× 131 1.4× 60 0.7× 26 1.1k
Ryan M. Franke United States 16 554 3.0× 286 1.9× 138 1.2× 15 0.2× 253 3.0× 22 1.1k
Todd Hill United States 10 236 1.3× 197 1.3× 64 0.5× 19 0.2× 63 0.7× 19 539
Patricia Bricmont United States 16 109 0.6× 231 1.5× 275 2.4× 159 1.7× 99 1.2× 18 665
Jacob Lund Denmark 14 32 0.2× 293 1.9× 30 0.3× 75 0.8× 33 0.4× 34 1.1k
R. Hulhoven Belgium 12 93 0.5× 114 0.7× 21 0.2× 68 0.7× 60 0.7× 38 472

Countries citing papers authored by Eugène Cox

Since Specialization
Citations

This map shows the geographic impact of Eugène Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugène Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugène Cox more than expected).

Fields of papers citing papers by Eugène Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugène Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugène Cox. The network helps show where Eugène Cox may publish in the future.

Co-authorship network of co-authors of Eugène Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Eugène Cox. A scholar is included among the top collaborators of Eugène Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugène Cox. Eugène Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dodds, Michael, Yuan Xiong, Samer Mouksassi, et al.. (2021). Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection. British Journal of Clinical Pharmacology. 87(9). 3388–3397. 9 indexed citations
4.
Li, Qin, Nancy R. Zhang, Junichi Ishigami, et al.. (2021). Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations. Journal of Human Hypertension. 36(11). 989–995. 3 indexed citations
5.
Namour, Florence, Paul M. Diderichsen, Eugène Cox, et al.. (2015). Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection. Clinical Pharmacokinetics. 54(8). 859–874. 113 indexed citations
6.
Maringwa, John, Matts Kågedal, Ulrika Wählby Hamrén, et al.. (2014). Pharmacokinetic–pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA). The Journal of Clinical Pharmacology. 55(3). 328–335. 11 indexed citations
7.
Namour, Florence, et al.. (2014). THU0123 Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach. Annals of the Rheumatic Diseases. 73. 220–221. 1 indexed citations
8.
Diderichsen, Paul M., Eugène Cox, Steven W. Martin, Adriaan Cleton, & Jakob Ribbing. (2013). Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β2-Agonist PF-00610355. Clinical Pharmacokinetics. 52(6). 443–452. 9 indexed citations
9.
Diderichsen, Paul M., Eugène Cox, Steven W. Martin, Adriaan Cleton, & Jakob Ribbing. (2013). Predicted heart rate effect of inhaledPF‐00610355, a long acting β‐adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease. British Journal of Clinical Pharmacology. 76(5). 752–762. 5 indexed citations
10.
Girgis, Ihab, Partha Nandy, Jeffrey S. Nye, et al.. (2010). Pharmacokinetic–pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age. Epilepsia. 51(10). 1954–1962. 33 indexed citations
11.
Babu, R. Jayachandra, William R. Ravis, Sue H. Duran, et al.. (2009). Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. Journal of Veterinary Pharmacology and Therapeutics. 32(4). 388–392. 4 indexed citations
12.
Claret, Laurent, Eugène Cox, Lynn McFadyen, et al.. (2006). Modeling and Simulation of Sexual Activity Daily Diary Data of Patients with Female Sexual Arousal Disorder Treated with Sildenafil Citrate (Viagra®). Pharmaceutical Research. 23(8). 1756–1764. 12 indexed citations
13.
Schellens, J. H. M., P Dombernowsky, Jim Cassidy, et al.. (2001). Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9. Anti-Cancer Drugs. 12(7). 583–590. 11 indexed citations
14.
Cox, Eugène, M.W.E. Langemeijer, J. M. Gubbens‐Stibbe, Keith T. Muir, & Meindert Danhof. (1999). The Comparative Pharmacodynamics of Remifentanil and Its Metabolite, GR90291, in a Rat Electroencephalographic Model . Anesthesiology. 90(2). 535–544. 51 indexed citations
15.
Cox, Eugène, et al.. (1999). A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron. Journal of Pharmacokinetics and Biopharmaceutics. 27(6). 625–644. 46 indexed citations
16.
Grasela, Thaddeus H., et al.. (1999). Population Pharmacokinetics of Lamotrigine Adjunctive Therapy in Adults with Epilepsy. The Journal of Clinical Pharmacology. 39(4). 373–384. 46 indexed citations
17.
Cox, Eugène, M.W.E. Langemeijer, & Meindert Danhof. (1998). Pharmacokinetic-pharmacodynamic Modelling of the Analgesic Effect of Alfentanil in the Rat Using Tooth Pulp Evoked Potentials. Journal of Pharmacological and Toxicological Methods. 39(1). 19–27. 5 indexed citations
18.
Cox, Eugène, Catherijne A. J. Knibbe, M.W.E. Langemeijer, et al.. (1998). Influence of Different Fat Emulsion-Based Intravenous Formulations on the Pharmacokinetics and Pharmacodynamics of Propofol. Pharmaceutical Research. 15(3). 442–448. 56 indexed citations
19.
Cox, Eugène, et al.. (1998). Pharmacokinetic‐pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation. British Journal of Pharmacology. 124(7). 1534–1540. 13 indexed citations
20.
Cox, Eugène, et al.. (1997). Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats. Journal of Pharmacological and Toxicological Methods. 38(2). 99–108. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalin Arends Breakdown of academic impact, for papers by Marc Hattenberger Breakdown of academic impact, for papers by Christodoulos Flordellis Breakdown of academic impact, for papers by Dennis Swearingen Breakdown of academic impact, for papers by Baoguang Han Breakdown of academic impact, for papers by Ryan M. Franke Breakdown of academic impact, for papers by Todd Hill Breakdown of academic impact, for papers by Patricia Bricmont Breakdown of academic impact, for papers by Jacob Lund Breakdown of academic impact, for papers by R. Hulhoven
Rankless by CCL
2026